Related Experiment Videos
IL-10 production and CD40L expression in patients with common variable immunodeficiency
1Department of Allergy and Clinical Immunology, La Sapienza University of Rome, Italy.
Scandinavian Journal of Immunology
|July 1, 1997
Summary
Common variable immunodeficiency (CVI) patients show normal interleukin-10 (IL-10) production, but CD40 ligand (CD40L) expression may be functionally defective in some cases, impacting IgG production.
Area of Science:
- Immunology
- Clinical Medicine
- Molecular Biology
Background:
- Common variable immunodeficiency (CVI) is characterized by impaired antibody production.
- The roles of CD40 ligand (CD40L) and interleukin-10 (IL-10) in CVI pathogenesis are not fully understood.
Purpose of the Study:
- To investigate CD40L expression and IL-10 production in CVI patients.
- To determine the potential contribution of these factors to impaired IgG production in CVI.
Main Methods:
- Flow cytometry was used to measure CD40L expression on peripheral blood mononuclear cells (PBMCs) from CVI patients and controls.
- IL-10 production was assessed after in vitro stimulation of PBMCs.
- In vitro IgG production was induced using anti-CD40 and cytokine stimulation.
Main Results:
- CD40L expression was comparable to controls in most CVI patients, but functional defects were observed in some.
- IL-10 production was similar in CVI patients and controls.
- In vitro stimulation induced significant IgG production in only one of 13 CVI patients tested.
Conclusions:
- Altered IL-10 production is unlikely to be a major factor in impaired IgG production in most CVI patients.
- While CD40L is often normally expressed, functional defects may contribute to CVI in a subset of patients.
- Further research is needed to elucidate the precise mechanisms underlying CVI pathogenesis.